Notifications

Home

Stocks
- Stock Screener
- Market Movers
- Insider Trades
- Upcoming Earnings
- Upcoming Dividends
Options
- Unusual Options Activity
- Implied Volatility Rank
- Volatility %Change
News
Upcoming IPOs

Cosmos Health Inc (COSM)

$0.31 0.00 (-0.42%)

Overview
Financial
Short Interest
Institutional Holdings
Dividends
Charts

Market Cap	19.15M
Revenue (ttm)	65.27M
Net Income (ttm)	-19.15M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-29.34%
Debt to Equity Ratio	0.46

Volume	7,042,600
Avg Vol	10,543,270
Day's Range	N/A - N/A
Shares Out	62.08M
Stochastic %K	75%
Beta	4.83
Analysts	Strong Buy
Price Target	$4.50

Company Profile

Cosmos Health Inc. manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, the United Arab Emirates, Albania, North Macedonia, and Cyprus. The company provides prescription medications, over-the-counter drugs, medical devices, food supplements, nutraceuticals, cosmetics and other healthcare products under the Sky Premium Life and Mediterranation brand names. It offers ASTO-CHOL (Pravastatin), Diorium (Omeprazole), HEART-FREE (Clopidogre...

Industry: Medical Distribution

Sector: Healthcare

Phone: 312 536 3102

Website: www.cosmoshealthinc.com

Address:

5 Agiou Georgiou Str, Pilea, Thessaloniki, Greece

Nobodycares777 Jul. 15 at 12:53 PM

$COSM tomorrow will be a good day 👍🏼

0 · Reply

Perlaksen Jul. 15 at 12:15 PM

$COSM has another 4 mill to buy back shares

0 · Reply

Stopcryin Jul. 15 at 12:07 PM

$COSM Shorts have the same game plan every day. Hit this stock early so it can't recover ... and there's not a damn thing this CEO @Akis1965 can do about it 😂

0 · Reply

Pdwzzzz Jul. 15 at 11:22 AM

$COSM I feel like some big news will drop soon that will blow the lid off this

1 · Reply

Perlaksen Jul. 15 at 10:31 AM

$COSM

0 · Reply

Perlaksen Jul. 15 at 10:28 AM

$COSM have until dec. 7 to teach 1$ compliance

0 · Reply

Perlaksen Jul. 15 at 10:25 AM

$COSM

0 · Reply

Stopcryin Jul. 15 at 10:07 AM

$COSM This company's blood continues to run through the streets of Greece. When is this CEO @Akis1965 going to end everyone's nightmare and just go ahead and announce a RS so retail can just write off their huge losses?

1 · Reply

Stopcryin Jul. 15 at 9:53 AM

$COSM 2 down ... 2 to go 😉

0 · Reply

William_H_Bonney Jul. 15 at 7:10 AM

$COSM yes and Siokas stated they might approve further repurchase beyond this initial $5M worth of shares. Can’t understand why they still short this stock. It’s quite obvious where this is going

1 · Reply

Cosmos Health stock buyback expands to 4.49M shares

Jul 14, 2026, 2:40 PM EDT - 18 hours ago

Cosmos Health Share Buyback Expands to 4.49 Million Shares; Continues Open Market Repurchases

2026-07-13T19:05:14.000Z - 1 day ago

Cosmos Health repurchases additional 215,000 common shares in open market

Jul 13, 2026, 3:00 PM EDT - 1 day ago

Cosmos Health Share Buyback Reaches 4.36 Million Shares; Continues Open Market Repurchases

2026-07-13T17:05:17.000Z - 1 day ago

Cosmos Health reports Libytec partnership to commercialize Diabit-IS X in Greece

Jul 13, 2026, 1:00 PM EDT - 1 day ago

Cosmos Health Accelerates Prescription Medicine Strategy with Libytec Partnership to Commercialize DIABIT-IS X in Greece

2026-07-10T15:00:12.000Z - 4 days ago

Cosmos Health launches subscription model

Jul 10, 2026, 10:55 AM EDT - 4 days ago

Cosmos Health Launches Subscription Model

2026-07-09T19:50:56.000Z - 5 days ago

Cosmos Health announces repurchase of additional 80,000 shares

Jul 9, 2026, 3:45 PM EDT - 5 days ago

Cosmos Health Expands Share Buyback to 4.14 Million Shares; Continues Open Market Repurchases

2026-07-08T19:55:19.000Z - 6 days ago

Cosmos Health announces repurchase of additional 190,000 shares

Jul 8, 2026, 3:40 PM EDT - 6 days ago

Cosmos Health Share Buyback Surpasses 4 Million Shares; Continues Open Market Repurchases

2026-07-07T18:30:11.000Z - 7 days ago

Cosmos Health announces repurchase of additional 230,000 shares

Jul 7, 2026, 2:27 PM EDT - 7 days ago

Cosmos Health Share Buyback Expands to 3.87 Million Shares; Continues Open Market Repurchases

2026-07-07T13:35:24.000Z - 7 days ago

Cosmos Health reports preliminary Q2 revenue $19.4M

Jul 7, 2026, 9:29 AM EDT - 7 days ago

Cosmos Health Reports Preliminary Record Q2 and H1 2026 Revenue, Up Over 30% Year-Over-Year; Continues Open Market Share Repurchases

2026-07-06T18:40:08.000Z - 8 days ago

Cosmos Health announces repurchase of additional 220,000 shares

Jul 6, 2026, 2:30 PM EDT - 8 days ago

Cosmos Health Share Buyback Increases to 3.64 Million Shares; Continues Open Market Purchases

2026-07-02T18:15:08.000Z - 12 days ago

Cosmos Health expands buyback with additional 770,000 share repurchase

Jul 2, 2026, 2:10 PM EDT - 12 days ago

Cosmos Health Expands Buyback to 3.42 Million Shares With Additional 770,000-Share Repurchase; Continues Open Market Purchases

Jul 1, 2026, 11:05 AM EDT - 13 days ago

Cosmos Health Completes Initial Repurchase of 2.65 Million Shares for $500,000; Continues Open Market Buybacks at Current Pace

2026-06-30T16:00:32.000Z - 14 days ago

Cosmos Health authorizes up to $5M share repurchase program

Jun 30, 2026, 11:55 AM EDT - 14 days ago

Cosmos Health Authorizes Up to $5 Million Share Repurchase Program

2026-06-26T16:35:09.000Z - 18 days ago

Cosmos Health signs distribution agreement with IMC

Jun 26, 2026, 12:30 PM EDT - 18 days ago

Cosmos Health Signs Distribution Agreement With IMC, Owner of Qatar's Largest Pharmacy Chain; Secures Initial Purchase Order of 31,000 Sky Premium Life Units

2026-06-25T19:40:17.000Z - 19 days ago

Cosmos Health’s Cana advances international patent application

Jun 25, 2026, 3:31 PM EDT - 19 days ago

Cosmos Health Advances International Patent Application for Its Proprietary Hydrogel Weight Management Platform Across the U.S., Europe, Australia, and Canada

Jun 24, 2026, 3:37 PM EDT - 20 days ago

Cosmos Health's C-Sept PRO Gains Strong Traction Across Leading Greek Public and Private Hospital Groups, With Annualized Sales Poised to Exceed $1.3 Million at Approximately 72% Gross Margin

2026-06-23T19:40:11.000Z - 21 days ago

Cosmos Health to deploy AI-powered call center

Jun 23, 2026, 3:35 PM EDT - 21 days ago

Cosmos Health Signs Agreement to Deploy Artificial Intelligence (AI)-Powered Call Center to Optimize Order Intake, Customer Communications, and Operating Efficiency

2026-06-22T14:40:08.000Z - 22 days ago

Cosmos Health builds contract manufacturing orderbook to over 25M units

Jun 22, 2026, 10:30 AM EDT - 22 days ago

Cosmos Health Builds Contract Manufacturing Orderbook to Over 25 Million Units; Division Positioned to Generate Over $10 Million in Recurring Annual Profit

Jun 18, 2026, 3:34 PM EDT - 26 days ago

CosmoFarm Delivers Record Q2 2026 Revenue of Over $15M, Representing $60+ Million Annualized Run-Rate; Adds Over 80 Pharmacies and Expands AI Automation and Facility Capacity

Jun 17, 2026, 3:35 PM EDT - 27 days ago

Cosmos Health Enters the $163 Billion Global Skincare Market; Sales Already Underway in the United States

Jun 17, 2026, 9:27 AM EDT - 27 days ago

Cosmos Health Signs 2.86 Million-Unit Contract Manufacturing Agreement With Pharmex S.A. Across Three Dermatological Products

Jun 15, 2026, 9:00 AM EDT - 4 weeks ago

Cosmos Health Provides Update on United States Portfolio; Four 18 Series Products Introduced With Projected Annualized Revenue Over $22.7M and Approximately $17.0M Gross Profit

2026-06-12T19:40:29.000Z - 4 weeks ago

Cosmos Health’s Cana wins contract manufacturing orders totaling 253,657 units

Jun 12, 2026, 3:33 PM EDT - 4 weeks ago

Cosmos Health Receives New Contract Manufacturing Orders Totaling 253,657 Units Across a Range of Medicines

Jun 12, 2026, 9:29 AM EDT - 4 weeks ago

Cosmos Health Reports Annualized Sales Exceeding $1.5M for Its C-Scrub and C-Sept Antiseptic Brands in the UK and Greece; Plans EU Expansion Targeting $7.4M in Revenue and $5.3M in Gross Profit

2026-06-11T19:35:09.000Z - 4 weeks ago

Cosmos Health to acquire Doc Pharma, terms undisclosed

Jun 11, 2026, 3:31 PM EDT - 4 weeks ago

Cosmos Health Signs LOI to Acquire Doc Pharma S.A., a European GMP Pharmaceutical Manufacturer, a Transformative Step Expected to Boost Assets, Profitability, Production Capacity, and Product Portfolio

2026-06-11T13:44:08.000Z - 4 weeks ago

Cosmos Health secures 180-day extension to regain Nasdaq compliance

2026-06-10T19:35:08.000Z - 4 weeks ago

Cosmos Health unit signs three-year contract with Verisfield

Jun 10, 2026, 3:32 PM EDT - 4 weeks ago

Cosmos Health Signs 3-Year Contract Manufacturing Agreement with Verisfield for 3.9 Million Units of VASCLOR GEST Progesterone Pessaries

Jun 10, 2026, 9:00 AM EDT - 5 weeks ago

Cosmos Health CEO Issues Letter to Shareholders: Building an Innovative AI-Driven Global Healthcare Platform — Record Growth with U.S. Expansion Underway

2026-06-09T19:35:10.000Z - 5 weeks ago

Cosmos Health unit wins contract manufacturing agreement with Provident Pharma

Jun 9, 2026, 3:30 PM EDT - 5 weeks ago

Cosmos Health Inaugurates State-of-the-Art Capsule Production Line with New 5-Year Contract Manufacturing Agreement with Provident Pharmaceuticals for 385,000 Units of CERTORUN

Jun 8, 2026, 10:00 AM EDT - 5 weeks ago

Cosmos Health Completes Acquisition of Strategic Intellectual Property and Expands Nanotechnology Investment Initiatives

Jun 5, 2026, 9:25 AM EDT - 5 weeks ago

Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Jun 4, 2026, 3:57 PM EDT - 5 weeks ago

Cosmos Health Achieves Pan-European Distribution for Sky Premium Life Across All 27 EU Member States Through Leading E-Commerce Platform Skroutz

Jun 4, 2026, 9:25 AM EDT - 5 weeks ago

Cosmos Health Identifies Approximately $20 Million in Non-Core Assets Available for Monetization to Accelerate Growth and Unlock Shareholder Value

Jun 1, 2026, 8:25 AM EDT - 6 weeks ago

Cosmos Health Enters $69 Billion Global Animal Health Industry with Veterinary C-Scrub Wash 4% Following Successful European Standard Testing Under EN 1656 and EN 1657

May 26, 2026, 9:34 AM EDT - 7 weeks ago

Cosmos Health Releases 2026–2029 Guidance: Targeting $200M Revenue, $71M Gross Profit, and $44M Adjusted EBITDA by 2029 — Building an Innovative, High-Margin Healthcare Platform with Strong Cash Generation

May 21, 2026, 2:20 PM EDT - 7 weeks ago

Cosmos Health Announces Expiration of 4,874,126 Series B Warrants Unexercised; ~38% of Total Outstanding Warrants

May 21, 2026, 9:15 AM EDT - 7 weeks ago

Cosmos Health Reports Q1 2026 Results: Revenue Up 31% to $17.9M, New Q1 Record; Total Liabilities Reduced by $4.5M; Stockholders' Equity Up 7.6%; Cash of $2.2M; Record Momentum Continues into Q2 with U.S. Expansion Underway

May 14, 2026, 9:00 AM EDT - 2 months ago

Cosmos Health, through its Subsidiary Cana Laboratories, Enters into an Advisory Agreement with the European Investment Bank (EIB) for the Financing of its €50M R&D Program; EIB Financing Represents up to 50%, or €25M, under the EIB's Venture Debt Program

May 12, 2026, 10:15 AM EDT - 2 months ago

Cosmos Health Announces Withdrawal of Registration Statement on Form S-1

May 11, 2026, 2:25 PM EDT - 2 months ago

Cosmos Health Projects Over $3.2 Million in Incremental Annual Revenue from Fort18 in the United States Within 12-18 Months

May 8, 2026, 11:25 AM EDT - 2 months ago

Cosmos Health Receives Updated Zacks Research Report: 2026 Revenue Forecast Raised to $103.2 Million, EPS Outlook Upgraded to Positive Territory, and $4.50 Valuation Reaffirmed

Apr 30, 2026, 12:50 PM EDT - 2 months ago

Cosmos Health Projects Over $2.5 Million in Incremental Annual Revenue from Cur18 in the United States Within 12-18 Months

Apr 21, 2026, 12:50 PM EDT - 3 months ago

Cosmos Health Introduces the "18 Series" in the United States - A Science-Driven Nutraceutical Platform Built on Patented Ingredients, Published Clinical Research, and Exact Clinical Dosing; Targeting a Portfolio of 18 Clinically Validated Products

Apr 20, 2026, 10:55 AM EDT - 3 months ago

Cosmos Health Accelerates U.S. Expansion: Liv18 Phase 1 Execution Complete; Production and Sales Commencing April 2026; Expected to Generate $5M+ in Annual Revenue at ~75% Gross Margins; Early U.S. Commercial Traction Observed Across Product Portfolio

Apr 17, 2026, 2:00 PM EDT - 3 months ago

Cosmos Health Continues US Expansion with Q2 Launch of Cur18 - a Clinically Studied, Patented Curcumin Next-Gen Therapy Supplement Delivering 39× Higher Bioavailability and Designed to Support Joint Health

Apr 16, 2026, 3:15 PM EDT - 3 months ago

Cosmos Health Advances AI Investments to Enhance Efficiency, Reduce Costs, Improve Customer Experience and Drive Sales Growth; Certain Operating Expenses May Decrease by Up to 30%

Apr 15, 2026, 9:25 AM EDT - 3 months ago

Cosmos Health Reports Full Year 2025 Results: Revenue Hits All-Time Record of $65.3M, Up 20%; Gross Profit Surges 83% to $7.9M; Gross Margin Expands 418 Basis Points; Adjusted EPS Improves 82%; Cash Position Up 10x to $3.5M; Record Growth Continues Into 2026 Across All Core Segments

Apr 13, 2026, 12:50 PM EDT - 3 months ago

Cosmos Health Receives Third Consecutive Purchase Order from Pharmalink for 60,000 Units of Sky Premium Life Products in the UAE; Cumulative Orders Reach 270,000 Units, Advancing 5-Year Goal of Over 3 million Units

Apr 10, 2026, 9:40 AM EDT - 3 months ago

Cosmos Health Reports No Impact from Iran and Middle East Conflict; Revenue Continues at All-Time High Levels; NOOR U.S. Expansion on Track to Exceed $12 Million Within 12 Months

Apr 8, 2026, 11:10 AM EDT - 3 months ago

Cosmos Health Continues Expansion in the United States with Q2 Launch of Liv18 - a Clinically Proven, Patented Supplement for Liver Fat Reduction

Apr 1, 2026, 11:42 AM EDT - 3 months ago

Cosmos Health Announces Successful EN 12791 Study Results for C-Scrub Wash 4%, Strengthening Expansion into Hospital and Surgical Markets

Mar 19, 2026, 12:45 PM EDT - 4 months ago

Cosmos Health Provides Update; Evaluates Options to Address Valuation Disconnect; Will Issue Updated Guidance Following FY 2025 Results; Record Growth Continues as Significant U.S. Expansion Underway, with Additional $12M+ in High-Margin Revenue Projected; Important R&D Updates Expected Following Finalization of Certain Anticipated Transactions

Nobodycares777 Jul. 15 at 12:53 PM

$COSM tomorrow will be a good day 👍🏼

0 · Reply

Perlaksen Jul. 15 at 12:15 PM

$COSM has another 4 mill to buy back shares

0 · Reply

Stopcryin Jul. 15 at 12:07 PM

$COSM Shorts have the same game plan every day. Hit this stock early so it can't recover ... and there's not a damn thing this CEO @Akis1965 can do about it 😂

0 · Reply

Pdwzzzz Jul. 15 at 11:22 AM

$COSM I feel like some big news will drop soon that will blow the lid off this

1 · Reply

Perlaksen Jul. 15 at 10:31 AM

$COSM

0 · Reply

Perlaksen Jul. 15 at 10:28 AM

$COSM have until dec. 7 to teach 1$ compliance

0 · Reply

Perlaksen Jul. 15 at 10:25 AM

$COSM

0 · Reply

Stopcryin Jul. 15 at 10:07 AM

1 · Reply

Stopcryin Jul. 15 at 9:53 AM

$COSM 2 down ... 2 to go 😉

0 · Reply

William_H_Bonney Jul. 15 at 7:10 AM

$COSM yes and Siokas stated they might approve further repurchase beyond this initial $5M worth of shares. Can’t understand why they still short this stock. It’s quite obvious where this is going

1 · Reply

Skoufa Jul. 15 at 6:34 AM

$COSM since the buyback program has started 2 weeks ago, the company has repurchased around 4.5 million shares, investing around $1 million. They mean serious business! Thats around 20% of the $5 million program and there are no signs of the company slowing down!

0 · Reply

sn0wball Jul. 15 at 4:29 AM

$COSM 💫

0 · Reply

2BeLikeMike Jul. 15 at 4:02 AM

$COSM $30 tomorrow

0 · Reply

Stopcryin Jul. 15 at 2:25 AM

$COSM Getting slammed overseas! Another disastrous day tomorrow thanks to this CEO @Akis1965

0 · Reply

Stopcryin Jul. 15 at 12:25 AM

$COSM Can we finally stop talking about this so called buyback? Compared to the offerings this company has done, the buybacks are useless peanuts having no effect on SP anymore.

0 · Reply

Stopcryin Jul. 15 at 12:21 AM

$COSM OUCH!

0 · Reply

Stopcryin Jul. 15 at 12:19 AM

$COSM Clueless

1 · Reply

Stopcryin Jul. 15 at 12:17 AM

$COSM Could be any day now. Remember when this CEO surprised everyone with one and said he was forced to do it? What a fraud!

1 · Reply

Stopcryin Jul. 15 at 12:14 AM

$COSM Yes ... Go into your bathroom and flush the toilet.

0 · Reply

Will3732 Jul. 14 at 11:59 PM

$COSM Look at this guy, all he does is go to each board and post about Reverse Splits or anything negative that he can. MrAlientrader 5:52 PM $PSQH wonder what are the management thinking now. I bet they did mot expect their stock price would drop 50% after RS like those scam penny stocks. The managment have now lost all their credibilities and institutes will cut their loss, offering without big discount is now almost impossible. Disaster management totally destroyed this company MrAlientrader 3:49 PM $PSQH NYSE granted them 18 month from Feb 2026 to gain compliance and they choose to do RS, they never cared about shareholders MrAlientrader 3:44 PM $PSQH looks like offering coming and institutes already knew this. They will

0 · Reply

Will3732 Jul. 14 at 11:41 PM

$COSM HAHAHA you know theres an extension for many months to come so no R/S, don't try to dupe people

0 · Reply

mrPerezMarc Jul. 14 at 10:44 PM

$COSM Due Diligence: Analyzing the Buyback, Financials, Risks, and Upcoming Catalysts. Their AGM is tomorrow July 15th, 2026 10 AM EDT. https://www.reddit.com/r/pennystocks/s/WvH0y9ObI9

0 · Reply

1.0.0